DNA methylation of the protein-tyro sine phosphatase SHP1 in Philadelphia (Ph) chromosome positive chronic myelogenous leukemia (CML).

被引：0
|
作者：
Hoshino, K
Yang, H
Canalli, AA
Sanchez-Gonzalez, B
Donato, N
Kantarjian, H
Issa, JP
Garcia-Manero, G
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1528
引用
收藏
页码：420A / 421A
页数：2
相关论文
共 50 条
  • [1] Transcription factor JunB is not methylated in Philadelphia (Ph) chromosome positive chronic myelogenous leukemia (CML).
    Hoshino, K
    Yang, H
    Canalli, AA
    Sanchez-Gonzalez, B
    Donato, N
    Kantarjian, H
    Issa, JP
    Garcia-Manero, G
    BLOOD, 2003, 102 (11) : 656A - 656A
  • [2] Thiotepa for treatment of thrombocytosis in patients with Philadelphia chromosome (Ph) - Positive chronic myelogenous leukemia (CML).
    RodriguezMonge, E
    Cortes, J
    OBrien, S
    Talpaz, M
    Kantarjian, H
    BLOOD, 1996, 88 (10) : 3530 - 3530
  • [3] Significance of C-MPL expression in Philadelphia chromosome (Ph)-positive chronic myelogenous leukemia (CML).
    Kantarjian, H
    Manshouri, PT
    Estrov, Z
    Talpaz, M
    OBrien, S
    Beran, M
    Pierce, S
    Estey, E
    Keating, M
    Albitar, M
    BLOOD, 1997, 90 (10) : 4000 - 4000
  • [4] INVITRO AND INVIVO STUDIES IN PHILADELPHIA CHROMOSOME NEGATIVE (PH1-) CHRONIC MYELOGENOUS LEUKEMIA (CML)
    GREENBERG, B
    HIRASUNA, J
    LEWIS, J
    EXPERIMENTAL HEMATOLOGY, 1976, 4 : 144 - 144
  • [5] FACTOR-V DEFICIENCY IN CHILDREN WITH PHILADELPHIA (PH1) POSITIVE CHRONIC MYELOGENOUS LEUKEMIA (CML)
    HASEGAWA, DK
    COCCIA, PF
    RAMSAY, NKC
    NESBIT, ME
    KRIVIT, W
    EDSON, JR
    BLOOD, 1977, 50 (05) : 269 - 269
  • [6] Prognostic Significance of the Lost of a Major Molecular Response In Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia (Ph plus CML)
    Valentin Garcia-Gutierrez, J.
    Herrera, Pilar
    Jimenez-Rolando, Marta
    Tenorio, Maria
    Calbacho, Maria
    Jesus Blanchard, M.
    Dolores Rey, Maria
    Ramos, Paloma
    Ramos, M. L.
    Lopez, Javier
    BLOOD, 2010, 116 (21) : 1408 - 1408
  • [7] INDUCTION OF TRUE REMISSION IN PHILADELPHIA-CHROMOSOME POSITIVE (PH1+) CHRONIC MYELOGENOUS LEUKEMIA (CML) WITH THE L15 PROTOCOL
    ARLIN, Z
    KEMPIN, S
    GEE, T
    GOTO, T
    CHAGANTI, R
    KOENIGSBERG, E
    CLARKSON, B
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 339 - 339
  • [8] CLINICAL AND PROGNOSTIC FEATURES OF PATIENTS WITH PHILADELPHIA-CHROMOSOME (PH1) POSITIVE CHRONIC MYELOGENOUS LEUKEMIA (CML) AND EXTRAMEDULLARY DISEASE (EMD)
    TERJANIAN, T
    KANTARJIAN, H
    KEATING, M
    MCCREDIE, K
    WALTERS, R
    FREIREICH, E
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 193 - 193
  • [9] PRESENCE OF PHILADELPHIA (PH) CHROMOSOME-NEGATIVE CELLS IN PH-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA
    OHYASHIKI, K
    OHYASHIKI, JH
    IWABUCHI, H
    TAUCHI, T
    IWABUCHI, A
    TOYAMA, K
    JAPANESE JOURNAL OF MEDICINE, 1990, 29 (01) : 7 - 12
  • [10] A pilot study of all-trans retinoic acid (ATRA) in patients with Philadelphia chromosome (Ph)-positive chronic myelogenous leukemia (CML).
    Cortes, J
    Kantarjian, H
    OBrien, S
    Beran, M
    Estey, E
    Keating, M
    Talpaz, M
    BLOOD, 1996, 88 (10) : 3515 - 3515
12345